EnzyPep is a venture capital-backed company that develops green, sustainable and cost-effective routes to synthesize pharmaceutical peptides and peptide conjugates with proteins and antibodies. CEPS (Chemo Enzymatic Peptide Synthesis). An enzymatic peptide ligation technology enabling:
a) Efficient industrial scale production of peptides for the growing market of biological pharmaceuticals.
b) Extension of the lifecycle of branded blockbusters.
c) Creation of a “gold standard” (no racemisation and improved overall purity).
d) Lower cost of goods in production (less purification required), faster production, higher throughput; less equipment utilization, reduced use of expensive equipment.
e) Creating shorter and more predictable development trajectories from synthesis strategy development start to experimental proof-of-principle of peptide assembly concept.